Kévin Bihan
- Co-authors
- Joe‐Elie SalemBénédicte Lebrun‐VignesChristian Funck‐BrentanoMathieu KernéisJavid J. MoslehiNicolas WeissEnora LaasFabien Reyal
- Topics
- Pharmacovigilance and Adverse Drug Reactions (7 papers)Drug-Induced Adverse Reactions (6 papers)Cancer Immunotherapy and Biomarkers (6 papers)
- Cited by
- ToxicologyOncologyMolecular Medicine
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Kévin Bihan
36 papers receiving 557 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 169
- Cardiology and Cardiovascular Medicine 108
- Pharmacology 85
- Infectious Diseases 71
- Toxicology 69
Countries citing papers authored by Kévin Bihan
This map shows the geographic impact of Kévin Bihan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Bihan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Bihan more than expected).
Fields of papers citing papers by Kévin Bihan
This network shows the impact of papers produced by Kévin Bihan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Bihan. The network helps show where Kévin Bihan may publish in the future.
Co-authorship network of co-authors of Kévin Bihan
This figure shows the co-authorship network connecting the top 25 collaborators of Kévin Bihan. A scholar is included among the top collaborators of Kévin Bihan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kévin Bihan. Kévin Bihan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspectivebreakdown → | 67 |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 21 | |
| 10 | 2 | |
| 11 | 3 | |
| 12 | 9 | |
| 13 | 12 | |
| 14 | 6 | |
| 15 | 81 | |
| 16 | 4 | |
| 17 | 12 | |
| 18 | 22 | |
| 19 | 114 | |
| 20 | 11 |
About Kévin Bihan
Kévin Bihan is a scholar working on Toxicology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 39 papers that have together received 572 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Drug-Induced Adverse Reactions (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Toxicology (69 citations), Oncology (169 citations) and Molecular Medicine (26 citations). Kévin Bihan has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Joe‐Elie Salem, Bénédicte Lebrun‐Vignes, Christian Funck‐Brentano, Mathieu Kernéis, Javid J. Moslehi, Nicolas Weiss, Enora Laas, Fabien Reyal, Jean‐Philippe Spano and Élise Dumas. Their work appears in journals such as Nature Communications, Annals of Oncology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.